Cryopreservation Equipment Market Size, Share & Forecast 2034

The Cryopreservation Equipment Market size is expected to reach US$ 23.95 billion by 2034, growing from an estimated US$ 8.91 billion in 2025. The market is anticipated to register a robust Compound Annual Growth Rate (CAGR) of 11.57% during the forecast period of 2026–2034.

Cryopreservation Equipment Market Analysis

The global cryopreservation equipment market forecast has a period of accelerated growth driven by a revolution in cell and gene therapy, along with a corresponding surge in biobanking activities globally. In structural terms, market growth is supported by the critical need for ultra-low temperature storage solutions as a means of retaining the viability and integrity of high-value biological assets, including patient-derived T-cells and delicate stem cell lines. This growth is further amplified by significant public and private investments pouring into personalized medicine research and the commercialization of novel regenerative treatments. The market expansion is actively facilitated by technological advancements, specifically the development of automated, vapor-phase liquid nitrogen storage systems and smart inventory management solutions that mitigate human error and ensure data compliance for clinical-grade samples.

Cryopreservation Equipment Market Overview

Cryopreservation equipment entails a wide range of specialized instrumentation and consumables utilized to halt biological functions and preserve cells, tissues, and whole organs at ultra-low temperatures, typically between –80°C and –196°C. This is achieved by the controlled application of cryogens, usually liquid nitrogen or its vapor phase, although frequently assisted via controlled-rate freezing mechanisms that minimize intracellular ice crystal formation. These systems form the backbone of the entire biobanking and regenerative medicine landscape by ensuring the long-term viability of materials utilized in clinical trials, fertility treatments, and therapeutic manufacturing. This critical equipment is used by key end-users such as commercial stem cell banks, large pharmaceutical and biotechnology enterprises, and academic research institutions to ensure the safety, traceability, and clinical readiness of irreplaceable biological inventory.

Strategic InsightsCryopreservation Equipment Market Drivers and Opportunities

Market Drivers:

• Rising Demand for Stem Cell Preservation and Regenerative Medicine: The increasing approval of cell and gene therapies (e.g., CAR-T therapy) and the proliferation of stem cell-based clinical trials are creating a critical, high-volume requirement for standardized, reliable cryopreservation infrastructure to handle valuable cellular starting materials and final products.
• Increasing Prevalence of Chronic Diseases Driving Biobanking Needs: The global rise in chronic and rare diseases necessitates larger and more diverse biological sample collections (biobanks) for diagnostic research, biomarker discovery, and clinical validation studies. Cryopreservation equipment is fundamental to ensuring the long-term integrity and accessibility of these collections.
• Technological Advancements in Cryogenic Storage Systems: Advances in cryogenic storage systems include innovative solutions focusing on increasing safety, energy efficiency, and automation. These include next-generation vapor-phase freezers that reduce the risk of cross-contamination and integrated cryogenic management software that helps ensure audit trails and compliance with GMP standards.

Market Opportunities:

• Expansion in Emerging Markets with Growing Healthcare Infrastructure: Developing nations, particularly in the Asia Pacific and Latin America, are rapidly investing in sophisticated healthcare and research infrastructure. This creates a vast, untapped opportunity for providers of cryopreservation solutions, especially scalable, modular systems that can meet rising demand efficiently.
• Development of Automated and Energy-Efficient Cryopreservation Systems: The high operational cost and manual nature of traditional cryostorage present a major opportunity. The manufacturers are working on the development of automated robotic handling systems and advanced vacuum-insulated cryogenic vessels that will greatly reduce energy consumption and labor while improving sample security.
• Strategic Partnerships for Innovation and Global Distribution: The collaboration between equipment manufacturers and specialized cryogenic logistics companies (like cold chain service providers) is very important in establishing strong global supply chains that can manage the highly sensitive "vein-to-vein" delivery cycle needed for personalized cell therapies.

Cryopreservation Equipment Market Report Segmentation Analysis

The cryopreservation equipment market share is analyzed across various segments based on function, cryogen source, clinical application, and end-user setting, providing a clearer understanding of market dynamics. Below is the standard segmentation approach used in most industry reports:

By Type:

• Freezers
• Sample Preparation Systems
• Accessories

By Cryogen Type:

• Liquid Nitrogen
• Oxygen
• Liquid Helium
• Argon

By Application:

• Cord Blood Stem Cells
• Sperms
• Semen
• Testicular Tissues
• Embryos & Oocytes
• Cell & Gene Therapies

By End User:

• Stem Cell Banks
• Biotechnology & Pharmaceutical Organizations
• Stem Cell Research Laboratories

Market Report ScopeCryopreservation Equipment Market Share Analysis by Geography

The adoption and growth of cryopreservation equipment solutions vary globally, influenced by R&D intensity, regulatory clarity, and healthcare expenditure. Below is a summary of market share and trends by region:

North America

• Market Share: Holds the largest market share globally due to the extensive presence of major biotech and pharma companies, significant R&D investment, and a robust regulatory framework (e.g., FDA) supporting cell and gene therapy clinical trials.
• Key Drivers: High concentration of contract development and manufacturing organizations (CDMOs) specializing in CGT; early adoption of automated cryogenic solutions.
• Trends: Shift toward fully automated, high-density biobanking facilities and increasing demand for customized cryo-logistics services to manage complex, global clinical supply chains.

Europe

• Market Share: Commands a significant share, driven by strong government support for stem cell research (e.g., EU funding programs) and a high number of public and private tissue banks.
• Key Drivers: Mandatory data governance and compliance requirements (e.g., GDPR) necessitate sophisticated sample tracking software; high clinical adoption of IVF and assisted reproductive technologies.
• Trends: Focus on standardizing sample processing across borders; rising demand for energy-efficient cryogenic freezers to meet sustainability targets.

Asia Pacific

• Market Share: Expected to be the fastest-growing region during the forecast period. Growth is propelled by massive population bases, rising healthcare expenditure, and government policies supporting indigenous biotech industries.
• Key Drivers: Rapid expansion of stem cell clinical research in countries like China, Japan, and South Korea; growing private sector investment in fertility clinics and cord blood banking.
• Trends: Adoption of cost-effective, smaller-scale cryopreservation units in new or rapidly expanding research centers; increasing need for localized service and technical support.

South and Central America

• Market Share: An emerging market with developing infrastructure, demonstrating moderate growth tied to the expansion of private medical centers and fertility clinics.
• Key Drivers: Growing awareness of fertility preservation options; public-private partnerships aimed at increasing biomedical research capabilities.
• Trends: Preference for modular and scalable LN2 systems; reliance on imported, clinically proven cryopreservation technology from established markets.

Middle East and Africa

• Market Share: A developing market with growth concentrated in high-income economies, driven by strategic national visions for healthcare diversification and excellence.
• Key Drivers: Large-scale government investment in medical cities and research hubs; establishment of regional stem cell therapy centers.
• Trends: Emphasis on acquiring premium, state-of-the-art cryopreservation and biobanking systems to ensure world-class quality for high-value research and therapeutic materials.

Cryopreservation Equipment Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

The cryopreservation equipment market is highly concentrated, with dominant global players offering a comprehensive portfolio from sample preparation to long-term storage and logistics. Competition is fierce, focusing on the technological sophistication and integration capability of equipment.

Vendors differentiate themselves through:

• Integrated Workflow Solutions: Providing seamless, end-to-end solutions that link controlled-rate freezing equipment with automated LN2 storage and inventory management software.
• Compliance and Safety: Offering systems pre-validated for GMP environments, featuring continuous remote monitoring, and designed with safety mechanisms to prevent temperature fluctuations and cryogen exposure.
• Scalability and Footprint: Developing high-density storage tanks and modular platforms that maximize sample capacity while minimizing the physical footprint and operational utility costs.

Opportunities and Strategic Moves

• Partnering with CGT Developers: Establishing agreements with cell and gene therapy companies to provide specialized, bespoke cryo-shipping containers and temperature-monitored logistics services.
• Incorporating IoT and AI: Utilizing Internet of Things (IoT) sensors for real-time temperature tracking and employing AI for predictive maintenance and optimization of cold chain logistics.
• Focus on Energy Efficiency: Marketing new-generation mechanical and LN2 freezers on the basis of reduced power consumption and lower lifecycle cost, a key decision factor for large-scale biobanks.

Major Companies operating in the Cryopreservation Equipment Market are:

1. Thermo Fisher Scientific Inc.
2. Brooks Automation, Inc.
3. Danaher Corporation
4. Avantor, Inc.
5. PHC Holdings Corporation
6. Hamilton Company
7. Cryoport Systems, LLC.
8. Gold Sim Cellular Science LLC
9. Antech Group Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Cryopreservation Equipment Market News and Recent Developments

• PHCbi introduced the MDF-C2156VANC-PA VIP Plus mechanical ultra-low freezer capable of achieving –150 °C through hybrid cascade refrigeration and high-performance VIP insulation. The unit incorporates robust alarm systems and contamination-free operation, supporting sustainable and secure cryogenic sample preservation.
• Cryoport partnered with Cell Matters to provide end-to-end cryopreservation services for leukapheresis-derived therapies, furthering the end-to-end support for advanced therapy supply chains. The company also focused on its automated, closed-system approach, IntegriCell®, for standardizing leukopak cryopreservation to improve cell viability and consistency in global distribution.

Cryopreservation Equipment Market Report Coverage and Deliverables

The “Cryopreservation Equipment Market Size and Forecast (2021–2034)” report provides a detailed analysis of the market covering the below areas:

• Cryopreservation Equipment Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Cryopreservation Equipment Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Cryopreservation Equipment Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Cryopreservation Equipment Market
• Detailed company profiles

REGIONAL FRAMEWORK MARKET PLAYERS

Download Free Sample

   Inquire for Discount   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
• Request discounts available for Start-Ups & Universities